Dose Adjustments to Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures

被引：0

作者：

Rosenfeld, William E. ^{[1
]}

Abou-Khalil, Bassel ^{[2
]}

Aboumatar, Sami ^{[3
]}

Bhatia, Perminder ^{[4
]}

Biton, Victor ^{[5
]}

Klein, Pavel ^{[6
]}

Krauss, Gregory L. ^{[7
]}

Sperling, Michael R. ^{[8
]}

Vossler, David G. ^{[9
]}

Wechsler, Robert ^{[10
]}

机构：

[1] Comprehens Epilepsy Care Ctr Children & Adults, New York, NY USA

[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[3] Austin Epilepsy Care Ctr, Austin, TX USA

[4] Neuro Pain Med Ctr, Fresno, CA USA

[5] Arkansas Epilepsy Program, Little Rock, AR USA

[6] Mid Atlantic Epilepsy & Sleep Ctr, North Bethesda, MD USA

[7] Johns Hopkins Univ, Baltimore, MD 21218 USA

[8] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[9] Univ Washington, Sch Med, Seattle, WA 98195 USA

[10] Idaho Comprehens Epilepsy Ctr, Boise, ID USA

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

1755

引用

页数：5

共 50 条

[1] Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
Rosenfeld, William E.
Abou-Khalil, Bassel
Aboumatar, Sami
Bhatia, Perminder
Biton, Victor
Krauss, Gregory L.
Sperling, Michael R.
Vossler, David G.
Klein, Pavel
Wechsler, Robert
EPILEPSIA, 2021, 62 (12) : 3016 - 3028
[2] Efficacy of Cenobamate by Concomitant Antiseizure Medications in Patients With Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study
Klein, Pavel
Vossler, David G.
Krauss, Gregory L.
Sperling, Michael R.
Kamin, Marc
Rosenfeld, William E.
NEUROLOGY, 2021, 96 (15)
[3] Post-hoc Analysis of the Effects of Dose Reductions of Concomitant Clobazam in a Phase 3, Open-Label Study of Cenobamate for the Treatment of Uncontrolled Focal Seizures
Abou-Khalil, Bassel
Ferrari, Louis
Klein, Pavel
Kim, Jessica
Krauss, Gregory L.
Vossler, David G.
Sperling, Michael R.
Rosenfeld, William E.
NEUROLOGY, 2021, 96 (15)
[4] Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures: Effects of Dose Reductions to Concomitant Lamotrigine and Carbamazepine
Ferrari, Louis
Nisman, Arkady
Sperling, Michael R.
Rosenfeld, William E.
NEUROLOGY, 2021, 96 (15)
[5] Efficacy of Cenobamate for Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study
Sperling, Michael R.
Abou-Khalil, Bassel
Aboumatar, Sami
Bhatia, Perminder
Biton, Victor
Klein, Pavel
Krauss, Gregory L.
Vossler, David G.
Wechsler, Robert
Ferrari, Louis
Kamin, Marc
Grall, Mindy
Rosenfeld, William E.
NEUROLOGY, 2021, 96 (15)
[6] Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study
Sperling, Michael R.
Abou-Khalil, Bassel
Aboumatar, Sami
Bhatia, Perminder
Biton, Victor
Klein, Pavel
Krauss, Gregory L.
Vossler, David G.
Wechsler, Robert
Ferrari, Louis
Grall, Mindy
Rosenfeld, William E.
EPILEPSIA, 2021, 62 (12) : 3005 - 3015
[7] Efficacy of cenobamate by focal seizure subtypes: Post-hoc analysis of a phase 3, multicenter, open-label study
Rosenfeld, William E.
Ferrari, Louis
Kamin, Marc
EPILEPSY RESEARCH, 2022, 183
[8] Concomitant Drug Load Reduction During Adjunctive Cenobamate Therapy: Post-hoc Analysis of a Phase 3, Open-Label Study
Aboumatar, Sami
Ferrari, Louis
Stern, Sean
Wade, Clarence
Weingarten, Mindl
Connor, Gregory S.
Rosenfeld, William E.
NEUROLOGY, 2023, 100 (17)
[9] PREDICTORS OF SUSTAINABILITY OF RESPONSE WITH CENOBAMATE: POST-HOC SUBSET ANALYSIS OF A PHASE 3, OPEN-LABEL STUDY
Stern, S.
Wechsler, R.
Kerr, W.
Wade, C.
Vossler, D. G.
Rosenfeld, W. E.
VALUE IN HEALTH, 2023, 26 (06) : S17 - S17
[10] Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study
Stern, Sean
Wechsler, Robert
Kerr, Wesley T.
Wade, Clarence T.
Vossler, David G.
Rosenfeld, William E.
NEUROLOGY, 2023, 100 (17)

← 1 2 3 4 5 →